What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter caseâcontrol study
Archives of Gynecology and Obstetrics Sep 07, 2017
Boyraz G, et al. – The clinicopathological qualities and oncological outcome of women with microinvasive Borderline ovarian tumor (BOTs) are explored in this study. Stromal microinvasion is essentially connected with reduced disease–free survival (DFS). In addition, this study affirms that the risk of recurrence is higher in patients with microinvasive BOT.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
